All In MedTech

FDA Clearance Tracker · P150016-S019

Tridyne Vascular Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 17, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 17, 2021

Approved

Time to decision

238 days

Received Dec 22, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150016-S019
Device name
Tridyne Vascular Sealant
Applicant
Neomend, Inc.
Applicant location
Irvine, CA
Received
Dec 22, 2020
Decided
Aug 17, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150016

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for replacing the 5mL sterile water vial with a 10mL vial.

Source documents

Other decisions for Neomend, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.